Solventum (SOLV) Cash from Investing Activities (2023 - 2026)
Solventum's (SOLV) quarterly Cash from Investing Activities came in at -$77.0 million in Q1 2026, up 32.46% YoY from -$58.1 million in Q1 2025, and up 89.66% on a QoQ basis from -$745.0 million in Q4 2025.
Solventum (SOLV) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Solventum (SOLV) has 4 years of Cash from Investing Activities data on file, last reported at -$77.0 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 32.46% year-over-year to -$77.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 billion (up 822.96% YoY) and the FY2025 annual result came in at $2.8 billion, up 836.05% from the prior year.
- Cash from Investing Activities advanced to -$77.0 million in Q1 2026, from -$745.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $3.8 billion in Q3 2025 to a low of -$745.0 million in Q4 2025.
- A 4-year average of $162.3 million and a median of -$88.0 million in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities tumbled 1450.0% — and 2025, when it jumped 4149.46%.
- Tracing SOLV's Cash from Investing Activities over 4 years: stood at -$88.0 million in 2023, then sank by 44.32% to -$127.0 million in 2024, then plunged by 486.61% to -$745.0 million in 2025, then soared by 89.66% to -$77.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$77.0 million (Q1 2026), -$745.0 million (Q4 2025), and $3.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -82.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -87.00 Mn |
| Jun 30, 2026 | -87.00 Mn |
| Mar 31, 2026 | -77.00 Mn |
| Mar 31, 2026 | -77.00 Mn |
| Dec 31, 2025 | -745.00 Mn |
| Dec 31, 2025 | -745.00 Mn |
| Sep 30, 2025 | 3.77 Bn |
| Sep 30, 2025 | 3.77 Bn |
| Jun 30, 2025 | -110.00 Mn |
| Jun 30, 2025 | -110.00 Mn |
| Mar 31, 2025 | -114.00 Mn |
| Mar 31, 2025 | -114.00 Mn |
| Dec 31, 2024 | -127.00 Mn |
| Dec 31, 2024 | -127.00 Mn |
| Sep 30, 2024 | -93.00 Mn |
| Sep 30, 2024 | -93.00 Mn |
| Jun 30, 2024 | -58.00 Mn |
| Jun 30, 2024 | -58.00 Mn |
| Mar 31, 2024 | -102.00 Mn |
| Mar 31, 2024 | -102.00 Mn |